Ivermectin cream is an topical medication primarily used to treat inflammatory lesions of rosacea (rosacea).

1、 Drug name

Ivermectin cream.

2、 Indications

Used to treat inflammatory skin lesions of rosacea (rosacea).

3、 Specifications and characteristics

1. Specification: Cream, with a concentration of 1%. Each gram of cream contains 10 milligrams of ivermectin.

2. Appearance: Cream.

4、 Main components

Active ingredient: Ivermectin.

5、 Usage and dosage

1. Usage: Apply topically once a day to the affected area of the face.

2. Dosage: Apply a pea sized amount evenly to each affected area (forehead, chin, nose, each cheek) in a thin layer.

3. Caution: Avoid contact with eyes and lips; Not for oral, ocular or vaginal use.

6、 Dose adjustment

Always follow the recommended usage and consult a doctor for any adjustments.

7、 Medication precautions

1. Before and after meals: If there is no specific requirement, it is recommended to use it regularly to maintain regularity.

2. Missed use: If missed, it should be replenished as soon as possible. If it is close to the next medication time, skip it and do not double the use.

3. Accidental ingestion: If accidentally ingested, immediately contact a doctor or go to the emergency room.

4. Vomiting: This product is for external use and is not suitable for vomiting.

5. Other: Tighten the child safety cover after use; Avoid squeezing the tube body to prevent leakage; For skin use only.

8、 Medication for special populations

1. Pregnant women: The existing data is insufficient to confirm the risk to the fetus. Animal studies have shown that high-dose oral administration may cause malformations, but topical creams have low systemic exposure and should be used after weighing the pros and cons.

2. Breastfeeding period: It is unknown whether there is milk secretion after topical use. Oral administration of ivermectin can be detected in milk, and a doctor should be consulted during use.

3. Children: Safety and efficacy have not yet been established.

4. Elderly patients: Clinical studies have shown no overall safety or efficacy difference compared to younger patients, but individual sensitivity still needs to be considered.

9、 Adverse reactions

1. Common reactions (incidence rate ≤ 1%): skin burning sensation, skin irritation.

2. Post market report: Contact dermatitis, allergic dermatitis.

10、 Contraindications

None.

11、 Drug interactions

In vitro studies have shown that at therapeutic concentrations, this product neither inhibits nor induces cytochrome P450 enzymes.

12、 Storage method

1. Storage temperature: 20 ° C-25 ° C (68 ° F-77 ° F), allowing short-term storage within the range of 15 ° C-30 ° C (59 ° F-86 ° F).

2. Other: Keep out of reach of children.

Ivermectininformation